Ex vivo expansions of megakaryocytopoiesis from placental and umbilical cord blood CD34+ cells in serum-free culture supplemented with proteoglycans extracted from the nasal cartilage of salmon heads and the nasal septum cartilage of whale

Life Sciences

Volumn 82, Issue 19-20, 2008, Pages 1023-1031

  Kashiwakura, Ikuo ^a   Takahashi, Kenji ^a   Monzen, Satoru ^a   Nakamura, Toshiya ^a   Takagaki, Keiichi ^b  

^a HIROSAKI UNIVERSITY   (Japan)

^b HIROSAKI UNIVERSITY   (Japan)

Author keywords

CD34+ cells; Ex vivo expansion; Megakaryocytopoiesis; Proteoglycan

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; INTERLEUKIN 3; PROTEOGLYCAN; THROMBOPOIETIN;

ANTIGEN EXPRESSION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; EX VIVO STUDY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; MONONUCLEAR CELL; NOSE CARTILAGE; NOSE SEPTUM; SALMON; THROMBOCYTOPOIESIS; UMBILICAL CORD BLOOD; WHALE;

ANIMALS; ANTIGENS, CD34; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; FEMALE; FETAL BLOOD; HUMANS; INTERLEUKIN-3; LEUKOCYTES, MONONUCLEAR; MEGAKARYOCYTES; NASAL SEPTUM; PLACENTA; PROTEOGLYCANS; SALMON; THROMBOPOIESIS; THROMBOPOIETIN; WHALES;

CETACEA;

EID: 42649143568     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2008.03.001     Document Type: Article

References (43)

1. Arai F., Hirao A., and Suda T. Regulation of hematopoietic stem cells by the niche. Trends in Cardiovascular Medicine 15 (2005) 75-79
2. Bruno E., Luikart S.D., Long M.W., and Hoffman R. Marrow-derived heparin sulfate proteoglycan mediates the adhesion of hematopoietic progenitor cells to cytokines. Experimental Hematology 23 (1995) 1212-1217
3. Calvi L.M., Adams G.B., Weibrecht K.W., Weber J.M., Olson D.P., Knight M.C., Martin R.P., Schipani E., Divieti P., Bringhurst F.R., Milner L.A., Kronenberg H.M., and Scadden D.T. Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 425 (2003) 841-846
4. Cohena Y., and Nagler A. Hematopoietic stem-cell transplantation using umbilical-cord blood. Leukemia Lymphoma 44 (2003) 1287-1299
5. Conget P., and Minguell J.J. IL-3 increases surface proteoglycan synthesis in haemopoietic progenitors and their adhesiveness to the heparin-binding domain of fibronectin. British Journal of Haematology 89 (1995) 1-7
6. Conrad P.D., and Emerson S.G. Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. Journal of Leukocyte Biology 64 (1998) 147-155
7. Devine S.M., Lazarus H.M., and Emerson S.G. Clinical application of hematopoietic progenitor cell expansion: current status and future prospects. Bone Marrow Transplantation 31 (2003) 241-252
8. Faham S., Hileman R.E., Fromm J.R., Linhardt R.J., and Rees D.C. Heparin structure and interactions with basic fibroblast growth factor. Science 271 (1996) 1116-1120
9. + human hematopoietic progenitor cells. Biomaterials 28 (2007) 836-843
10. Graham G.J., and Wright E.G. Haemopoietic stem cells: their heterogeneity and regulation. Int Journal of Experimental Pathology 78 (1997) 197-218
11. Gluckman E. Current status of umbilical cord blood hematopoietic stem cell transplantation. Experimental Hematology 28 (2000) 1197-1205
12. Gupta P., McCarthy J.B., and Verfaillie C.M. Stromal fibroblast heparan sulfate is required for cytokine-mediated ex vivo maintenance of human long-term culture-initiating cells. Blood 87 (1996) 3229-3236
13. Gupta P., Oegema Jr. T.R., Brazil J.J., Dudek A.Z., Slungaard A., and Verfaillie C.M. Structurally specific heparan sulfates support primitive human hematopoiesis by formation of a multimolecular stem cell niche. Blood 92 (1998) 4641-4651
14. Gupta P., Oegema Jr. T.R., Brazil J.J., Dudek A.Z., Slungaard A., and Verfaillie C.M. Human LTC-IC can be maintained for at least 5 weeks in vitro when interleukin-3 and a single chemokine are combined with O-sulfated heparan sulfates: requirement for optimal binding interactions of heparan sulfate with early-acting cytokines and matrix proteins. Blood 95 (2000) 147-155
15. Han Z.C., Briere J., Abgrall J.F., Sensebe L., Parent D., and Guern G. Characteristics of megakaryocyte colony formation in normal individuals and in primary thrombocythemia: studies using an optimal cloning system. Experimental Hematology 17 (1989) 46-52
16. Hascall V.C., and Sajdera S.W. Physical properties and polydispersity of proteoglycan from bovine nasal cartilage. The Journal of Biological Chemistry 245 (1970) 4920-4930
17. + cells prepared from human placental and umbilical cord blood. Radiation Research 166 (2006) 345-351
18. Kashiwakura I., Teramachi T., Kakizaki I., Takagi Y., Takahashi T.A., and Takagaki K. The effects of glycosaminoglycans on thrombopoietin-induced megakaryocytopoiesis. Haematologica 91 (2006) 1-9
19. Kato M., Wang H., Kainulainen V.V., Fitzgerald M.L., Ledbetter S., Ornitz D.M., and Bernfield M. Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2. Nature Medicine 4 (1998) 691-697
20. Klein G. The extracellular matrix of the hematopoietic microenvironment. Experientia 51 (1995) 914-926
21. Kuter D.J., and Begley C.G. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood 100 (2002) 3457-3469
22. Laughlin M.J., Barker J., Bambach B., Koc O.N., Rizzieri D.A., Wagner J.E., Gerson S.L., Lazarus H.M., Cairo M., Stevens C.E., Rubinstein P., and Kurtzberg J. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. The New England Journal of Medicine 344 (2001) 1815-1822
23. Long M.W. Blood cell cytoadhesion molecules. Experimental Hematology 20 (1992) 288-301
24. Majima M., Takagaki K., Sudo S., Yoshihara S., Kudo Y., and Yamagishi S. Effect of proteoglycan on experimental colitis. In: Endo M. (Ed). New developments in glycomedicine, Excepta Medica International Congress Series, No.1223 (2001), Elsevier Science, Amsterdam 221-224
25. + cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner. Blood 97 (2001) 3075-3085
26. Modrowski D., Lomri A., and Marie P.J. Glycosaminoglycans bind granulocyte- macrophage colony-stimulating factor and modulate its mitogenic activity and signaling in human osteoblastic cells. Journal of Cellular Physiology 177 (1998) 187-195
27. Möhle R., and Kanz L. Hematopoietic growth factors for hematopoietic stem cell mobilization and expansion. Seminars in Hematology 44 (2007) 193-202
28. Moore M.A., and Hoskins I. Ex vivo expansion of cord blood-derived stem cells and progenitors. Blood Cells 20 (1994) 468-479
29. Nietfeld J.J. Cytokines and proteoglycans. Experientia 49 (1993) 456-469
30. Oegema Jr. T.R., Hascall V.C., and Dziewiatkowski D.D. Isolation and characterization of proteoglycans from the swarm rat chondrosarcoma. The Journal of Biological Chemistry 250 (1975) 6151-6159
31. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 81 (1993) 2844-2853
32. Oike Y., Kimata K., Shinomura T., Nakazawa K., and Suzuki S. Structural analysis of chick-embryo cartilage proteoglycan by selective degradation with chondroitin lyases (chondroitinases) and endo-beta-d-galactosidase (keratanase). Biochemical Journal 191 (1980) 193-207
33. Ornitz D.M., Herr A.B., Nilsson M., Westman J., Svahn C.-M., and Waksman G. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 268 (1995) 432-436
34. Reiffers J., Cailliot C., Dazey B., Attal M., Caraux J., and Boiron J.M. Abrogation of post-myeloablative chemotherapy neutropenia by ex vivo expanded autologous CD34-positive cells. Lancet 354 (1999) 1092-1093
35. Roberts R., Gallagher J., Spooncer E., Allen T.D., Bloomfield F., and Dexter T.M. Heparan sulfate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature 332 (1988) 376-378
36. Rubinstein P., Carrier C., Scaradavou A., Kurtzberg J., Adamson J., Migliaccio A.R., Berkowitz R.L., Cabbad M., Dobrila N.L., Taylor P.E., Rosenfield R.E., and Stevens C.E. Outcomes among 562 recipients of placental-blood transplants from unrelated donors. The New England Journal of Medicine 339 (1998) 1565-1577
37. Simmons P.J., Levesque J.P., and Zannettino A.C. Adhesion molecules in haemopoiesis. Baillieres Clinics in Haematology 10 (1997) 485-505
38. + cells from purified adult human bone marrow and umbilical cord blood hematopoietic progenitor cells. Progress in Clinical and Biological Research 389 (1994) 385-391
39. Yoder M.C., and Williams D.A. Matrix molecule interactions with hematopoietic stem cells. Experimental Hematology 23 (1995) 961-967
40. Zauli G., Vitale L., Brunelli M.A., and Bagnara G.P. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood. Experimental Hematology 20 (1992) 850-854
41. Zhang J., Niu C., Ye L., Huang H., He X., Tong W.G., Ross J., Haug J., Johnson T., Feng J.Q., Harris S., Wiedemann L.M., Mishina Y., and Li L. Identification of the haematopoietic stem cell niche and control of the niche size. Nature 425 (2003) 836-841
42. Zubler R.H. Ex vivo expansion of haematopoietic stem cells and gene therapy development. Swiss Medical Weekly 136 (2006) 795-799
43. Zweegman S., Veenhof M.A., Huijgens P.C., Schuurhuis G.J., and Drager A.M. Regulation of megakaryocytopoiesis in an in vitro stroma model: preferential adhesion of megakaryocytic progenitors and subsequent inhibition of maturation. Experimental Hematology 28 (2000) 401-410